Healthcare News
Mounjaro outperforms Ozempic for weight loss, finds study
People taking tirzepatide (Mounjaro, Zepbound) dropped significantly more pounds than those taking semaglutide (Ozempic, Wegovy), researchers reported July 8 in the journal JAMA Internal Medicine.
Exercise and GLP-1 RA appears effective for weight loss while preserving bone mineral density
For adults with obesity, without diabetes, combining exercise with the glucagon-like peptide-1 receptor agonist (GLP-1 RA), liraglutide, is effective for weight loss, while preserving bone health, according to a study published online June 25 in JAMA Network Open.
Experts weigh in on new generation of weight loss medications
We've all seen the ads and read about celebrities who have successfully lost weight using one of the new weight loss medications like Ozempic, Wegovy and Zepbound that have exploded in popularity over the past year. But we've experienced the phenomenon of miracle weight loss diets and medications coming onto the scene before. Is the current crop another "flash in the pan?"
Meal replacement plus financial incentives found to be beneficial for teens with obesity
For adolescents with severe obesity, meal replacement therapy (MRT) plus financial incentives (FIs) yield a greater reduction in body mass index (BMI) and total body fat mass than MRT alone, according to a study published online June 17 in JAMA Pediatrics.
Nuts could be the next best thing when it comes to weight loss, research suggests
New research from the University of South Australia shows that including nuts in calorie-controlled weight loss diets does not hinder weight loss, and instead may have the opposite effect.
